Ana M. Borras

Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

J. A. Engelman, Toru Mukohara, Kreshnik Zejnullahu et al. · Journal of Clinical Investigation · 2006 · 457 citations · Full text

Engineering, Egfr-amplified Lung Cancer, Pathology +20

Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing

Roman K. Thomas, Elizabeth Nickerson, Jan Fredrik Simons et al. · Nature Medicine · 2006 · 385 citations

Dna Sequencing, Sequencing, Engineering +13

Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer

David M. Jackman, Beow Y. Yeap, Neal I. Lindeman et al. · Journal of Clinical Oncology · 2007 · 306 citations

Response and Resistance in a Non–Small-Cell Lung Cancer Patient With an Epidermal Growth Factor Receptor Mutation and Leptomeningeal Metastases Treated With High-Dose Gefitinib

David M. Jackman, Alison J. Holmes, Neal I. Lindeman et al. · Journal of Clinical Oncology · 2006 · 256 citations · Full text

A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening

Pasi A. Jänne, Ana M. Borras, Yanan Kuang et al. · Clinical Cancer Research · 2006 · 218 citations